BioCentury
ARTICLE | Company News

Serono in-licenses BioMarin's Phenoptin, Phenylase

May 17, 2005 2:08 AM UTC

BioMarin (BMRN; SWX:BMRN) and Serono (SWX:SEO; SRA) partnered to develop and market BMRN's Phenoptin sapropterin and Phenylase phenylalanine ammonia lyase. SEO has exclusive rights to market the compo...